Stockreport

Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability [Yahoo! Finance]

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF TheFly reported on April 7 that Jefferies lowered its price target on ABUS from $7.00 to $5.50 while maintaining a Buy rating. The revision was driven by updated expect [Read more]